Elisabeth Moreno to join Sanofi's Diversity, Equity and Inclusion Board
Paris: Sanofi has announced the appointment of Elisabeth Moreno, former French Minister for Gender Equality, Diversity and Equal opportunities, to its Diversity, Equity and Inclusion (DE&I) Board for the next three years.
Created in 2022 at the executive level with the aim to accelerate Sanofi’s DE&I agenda globally, this advisory council’s role is to support Sanofi’s DE&I strategy, to monitor progress on the company’s 2025 goals and to advise on how to amplify its impact in this space.
Elisabeth Moreno said, “By valuing diversity, equity and promoting inclusion, organizations can foster a sense of belonging among all employees, create a more innovative work environment and better serve their customers. I am happy to join an international organization that can impact millions of people across the planet not only using science to improve lives but also spreading values to inspire its employees and ecosystem. Together with Caroline Casey and Rohini Anand, I will bring my expertise to support Sanofi’s executive team think and implement its strategy to build a more resilient, sustainable and inclusive business through responsible initiatives with positive economic, social and environmental impact.”
With the appointment of Elisabeth Moreno and alongside with award-winning social entrepreneur Caroline Casey and DE&I pioneer and renowned thought-leader Dr. Rohini Anand, Sanofi’s DE&I Board comprises three of the most influential voices in the DE&I space. This advisory council also features Sanofi CEO Paul Hudson, five Sanofi Executive Committee members, Sanofi’s Chief Diversity Officer and representation from our global Employee Resource Groups.
Read also: AstraZeneca, Sanofi, Sobi simplify contractual agreements for Nirsevimab
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd